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The heme biosynthetic pathway of the malaria para-
site is a drug target and the import of host -aminolevu-
linate dehydratase (ALAD), the second enzyme of the
pathway, from the red cell cytoplasm by the intra
erythrocytic malaria parasite has been demonstrated
earlier in this laboratory. In this study, ALAD encoded
by the Plasmodium falciparum genome (PfALAD) has
been cloned, the protein overexpressed in Escherichia
coli, and then characterized. The mature recombinant
enzyme (rPfALAD) is enzymatically active and behaves
as an octamer with a subunit Mr of 46,000. The enzyme
has an alkaline pH optimum of 8.0 to 9.0. rPfALAD does
not require any metal ion for activity, although it is
stimulated by 20–30% upon addition of Mg2. The en-
zyme is inhibited by Zn2 and succinylacetone. The
presence of PfALAD in P. falciparum can be demon-
strated by Western blot analysis and immunoelectron
microscopy. The enzyme has been localized to the api-
coplast of the malaria parasite. Homology modeling
studies reveal that PfALAD is very similar to the enzyme
species from Pseudomonas aeruginosa, but manifests
features that are unique and different from plant ALADs
as well as from those of the bacterium. It is concluded
that PfALAD, while resembling plant ALADs in terms of
its alkaline pH optimum and apicoplast localization, dif-
fers in its Mg2 independence for catalytic activity or
octamer stabilization. Expression levels of PfALAD in
P. falciparum, based on Western blot analysis, immuno-
electron microscopy, and EDTA-resistant enzyme activ-
ity assay reveals that it may account for about 10% of the
total ALAD activity in the parasite, the rest being
accounted for by the host enzyme imported by the par-
asite. It is proposed that the role of PfALAD may be
confined to heme synthesis in the apicoplast that may
not account for the total de novo heme biosynthesis in
the parasite.
Studies in this laboratory had demonstrated that the ma-
laria parasites (Plasmodium falciparum and Plasmodium
berghei) are capable of heme biosynthesis de novo, despite
acquiring large amounts of heme from the host red cell hemo-
globin in the intraerythrocytic stage (1, 2). Inhibition of the de
novo heme biosynthetic pathway leads to death of the parasite
and the pathway is therefore a drug target (1–3). Studies on the
enzymes of the heme-biosynthetic pathway have revealed that
the first enzyme, -aminolevulinate synthase, is coded for by
the parasite genome and is localized in the parasite mitochon-
drion (4, 5). Studies from this laboratory have shown that the
second enzyme of the pathway, -aminolevulinate dehydratase
(ALAD),1 in the parasite is of host origin and evidence was
provided to show that the enzyme is translocated (imported)
from the host red cell into the parasite and is functional (2, 3).
At the same time genome sequence data available for P.
falciparum indicates that the parasite genome codes for ALAD
(PfALAD) and other enzymes of the heme-biosynthetic path-
way. Sato et al. (6) have shown by phylogenetic amino acid
sequence analysis derived from truncated cDNA, including the
metal-cofactor binding region and the active site, that PfALAD
is more closely related to the Mg2-binding enzyme species
from plant and algal plastids than the Zn2-binding species
from animals and fungi. Subsequently, Sato and Wilson (7)
have shown that the full-length PfALAD cDNA can comple-
ment a hemB mutant (ALAD/) of Escherichia coli, indicating
that the cDNA codes for a functional enzyme. These workers
have also predicted the following. 1) PfALAD probably requires
Mg2 as a cofactor, although the metal ion may not serve as an
allosteric activator. 2) It is possible that the intrinsic PfALAD
is responsible for de novo heme synthesis in the parasite rather
than the imported host enzyme.
It is therefore of interest to study the PfALAD in detail
experimentally. In the present study, parasite gene-coded
PfALAD-cDNA has been cloned and expressed in E. coli. The
properties of the purified recombinant enzyme have been stud-
ied in detail, especially its metal ion requirement for activity.
The enzyme has been modeled to explain some of its unique
properties. It has been possible to raise antibodies that specif-
ically interact with PfALAD and with these antibodies the
localization of the enzyme in P. falciparum in culture has been
studied by Western blot analysis and immunoelectron micros-
copy. Finally, based on studies on catalytic activity, inhibitor
sensitivity, and localization of PfALAD, an assessment of the
contribution of PfALAD to the total ALAD activity of the par-
asite in relation to the contribution of the imported host en-
zyme has been made.
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EXPERIMENTAL PROCEDURES
Materials—Full-length mouse erythroid ALAD-cDNA clone was a
kind gift from Dr. Terry Bishop, Johns Hopkins University, Baltimore,
MD. Anti-mouse and anti-rabbit secondary antibodies were purchased
from Invitrogen (ALP conjugates) or Pelco International (gold conju-
gates). All other chemicals were obtained from either Sigma or
Invitrogen.
Parasite Maintenance and Isolation—P. falciparum culture was
maintained on human O red blood cells by the candle jar method (8).
The cells were pelleted down and the parasites, essentially at the
trophozoite stage, were isolated by treatment with 0.15% (w/v) saponin
(9) or osmotic lysis (10) with slight modifications. For the latter proce-
dure, packed infected erythrocytes were treated with 40 volumes of cold
10 mM potassium phosphate buffer, pH 7.4, mixed thoroughly and
allowed to stand on ice for 10 min. The released parasites following lysis
of the red cells were pelleted down and washed once again with the
same buffer. The parasite pellet was subsequently washed three times
with phosphate-buffered saline. With both procedures, the final washes
were tested for possible hemoglobin or erythroid ALAD presence and
were found to be undetectable.
Cloning of PfALAD cDNA—The full-length cDNA (cDNA-1) sequence
of PfALAD was obtained from the genome data base and the sequence
provided by Sato and Wilson (7). Reverse transcriptase-PCR amplifica-
tion was carried out using the primer pair, PfALAD-1 (5-ATGT-
TAAAATCAGATGTAGTGC-3) and PfALAD-5 (5-TCATAGAGTT-
AATTCAATATTTAAA-3) to give a 1356-bp fragment (1–451 amino
acids). A second cDNA (cDNA-2) was obtained using the primer
pair, PfALAD-2 (5-AATTCACAAATATTAAGTAAAATGAA-3) and
PfALAD-5 to give a 1191-bp fragment (56–451 amino acids). A third
cDNA (cDNA-3) was obtained using the primer pair PfALAD-3 (5-
CACAAATATAAAGACATCGAAACTT-3) and PfALAD-4 (5-TCATC-
CCCCTCTATAATATGTTTATCCA-3) to give a 675-bp product (115–
340 amino acids) (Fig. 1, A–C). Because the primers were designed with
EcoRI/BamHI linkers, all cDNAs (cDNA-1, -2, and -3) were cloned into
pRSET vectors (Invitrogen, CA) at the BamHI-EcoRI site and proteins
were expressed in E. coli BL21(DE3) after isopropyl-1-thio--D-galacto-
pyranoside induction. Whereas the expression of cDNA-1 was very poor,
cDNA-2 (56–451 aa) and cDNA-3 (115–340 aa) could be expressed in
pRSET A vector. cDNA-2 was also cloned into PGEX4T1 vector to
express the protein as GST fusion. In both cases, the E. coli cells were
initially grown to an A600 of 1 at 30 °C with constant shaking at 200
rpm. The culture was then shifted to 18 °C and shaken at 150 rpm for
30 min before isopropyl-1-thio--D-galactopyranoside (0.5 mM) addition.
Induction was carried out for 15 h. These conditions resulted in cDNA-2
being expressed in the soluble phase. In the case of His-tagged protein
the frozen E. coli cells were lysed in lysis buffer (50 mM Tris buffer, pH
8.5) by sonication. The supernatant after centrifugation (20,000 rpm for
30 min) was subjected to ammonium sulfate fractionation (0–35%). The
pellet was resuspended in 50 mM Tris, pH 8.5, containing 300 mM KCl
and bound to nickel-agarose (Qiagen). After washing the column with
equilibration buffer and the buffer containing 0.1% Triton X-100 (w/v)
and 30 mM imidazole, the bound protein was eluted with a 30–300 mM
imidazole gradient in the same buffer containing 0.1% Triton X-100.
The peak fractions containing the protein were pooled, dialyzed against
50 mM Tris, pH 8.5, containing 20% glycerol, and stored at 20 °C.
In the case of the GST fusion protein, the recombinant E. coli lysate
obtained with 50 mM Tris, pH 8.5, containing 0.5% Triton X-100 was
centrifuged and the supernatant was directly loaded onto GST-agarose
(Sigma) and washed with the same buffer containing 300 mM KCl. The
protein was eluted with 50 mM Tris, pH 8.5, containing 30 mM GSH. The
peak fractions were pooled and incubated with thrombin for 15 h at 4 °C
to cleave the GST. The protein was purified on a Superdex-200 gel
filtration column and equilibrated with 50 mM Tris, pH 8.5, containing
300 mM KCl using AKTA purifier (Amersham Biosciences). The frac-
tions containing the enzyme were pooled and concentrated by ultrafil-
tration using a 50-kDa cut-off membrane (VivaScience). cDNA-3 (115–
340 aa) was also expressed with histidine tag, but the protein was
present in inclusion bodies. It was solubilized using 8 M urea and
purified using the nickel-agarose column. The urea was dialyzed out
after the protein was eluted from the column. cDNA-2 (56–451 aa)
expressed with histidine tag or as a GST fusion protein (before and after
removal of GST) was enzymatically active and was used as the source of
the recombinant PfALAD (rPfALAD) in this study. The product of
cDNA-3 (115–340 aa) expression is referred to as rPfALAD in this
study and was used to obtain PfALAD-specific antibodies.
Native human ALAD was purified from human red blood cells by a
slight modification of the known procedure (11). Briefly, the soluble red
cell supernatant was subjected to DEAE-Sephacel chromatography,
ammonium sulfate fractionation (0–45%), octyl-Sepharose and phenyl-
Sepharose chromatography. The last two chromatography steps were
repeated to obtain a pure preparation and this was used to raise
antibodies to the host ALAD. Recombinant mouse ALAD (rmALAD)
was purified as a protein with histidine tag from the clone (gift) and
used to study the properties in comparison with rPfALAD. The mam-
malian enzyme species are highly conserved (12) and the properties of
the mouse and human enzymes are very similar.
Enzyme Assay—ALAD enzyme activity was assayed in a total volume
of 0.1 ml in a mixture containing 25 mM Trizma (Tris base) (to cover the
pH range 7 to 9). Routine assays were carried out at pH 7.5 (25 mM
PIPES) and 8.5 (25 mM Tris), in the presence of 5 mM ALA, 5 mM
-mercaptoethanol, and enzyme (0.5 to 2.0 g of recombinant proteins
or 150–200 g of protein of parasite extract). The mixture was incu-
bated at 37 °C for 1 h and the porphobilinogen (PBG) formed was
estimated using modified Ehrlich reagent (13). No buffer ion effect as
such on enzyme activity was seen. While studying the effects of EDTA
or o-phenanthroline, the enzymes were first incubated with the chelator
for 20–30 min before the addition of metal ions and ALA. A molar
extinction coefficient for PBG of 60,200 M1 cm1 was used to quanti-
tate PBG concentration. The specific activity of rmALAD ranged mostly
between 22 and 26 mol of PBG/mg of protein/h at pH 7.5. The corre-
sponding values for rPfALAD ranged between 3 and 4 mol of PBG/mg
of protein/h at pH 8.5 and 2–2.5 mol of PBG/mg of protein/h at pH 7.5.
Determination of Mg2 Binding by Atomic Absorption—Metal ion
stoichiometry was determined by atomic absorption using a Thermo
Jarrell Ash Video 11E aa/ae spectrometer. Purified rPfALAD (5 ml, 400
g of protein/ml), isolated with a histidine tag, was dialyzed against 500
ml of Tris buffer (100 mM, pH 8.5) containing 20% glycerol with three
changes at 4-h intervals. The enzymatically active preparation was
used to measure the intrinsic Mg2 content.
PfALAD Homology Modeling—Alignment of the sequence (accession
FIG. 1. Scheme for ALAD, cDNA am-
plification. Three different cDNAs were
made using reverse transcriptase-PCR
amplification of RNA isolated from P. fal-
ciparum. The length of cDNA products in
nucleotide and amino acid (aa) coverage is
indicated. The stippled portion in A indi-
cates the postulated region encompassing
the signal and transit peptide sequences.
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number CAC82990/Q8MYK5) of PfALAD with the sequence neighbors
identified by a BLAST (14) search of the Non-Redundant and Protein
Data Bank (15) data bases, indicated ALAD from P. aeruginosa
(PsALAD, Protein Data Bank codes 1B4K and 1GZG) (16, 17) to be the
closest structural template with sequence similarities of 56% (E value:
3e50) over 330 amino acid residues. The alignment with the template,
when carefully verified by examining additional pairwise (18) and mul-
tiple alignments (19) with other closely related sequences, indicated a
few local frameshifts as judged by the position of well conserved known
functional residues, which were then corrected by minor editing. The
model of the mature polypeptide of a subunit was built using Insight-II
(Accelrys Inc.) using homology modeling protocols. The few insertions in
the PfALAD were built using the distance matrix-based loop searching
method available in Insight-II. The model was then soaked in a 5-Å
layer of water molecules and energy was minimized initially using a
steepest descent algorithm and then with a conjugate gradient mini-
mizer. The octamer of PfALAD was built based on the octamer in
PsALAD and the components were energy minimized individually as
dimers and tetramers. PfALAD model was also compared with the
structure of human erythrocyte ALAD (hALAD, Protein Data Bank
code 1E51). Structural comparisons were carried out through a DALI
(20) analysis. Various manipulations and analyses were carried out
using Insight-II.
Localization of ALAD in P. falciparum—The parasite in culture was
used to analyze for host and PfALAD by Western blot analysis and
immunoelectron microscopy. For Western blot analysis, purified
rPfALAD, partially purified native human ALAD, as well as parasite
extracts were subjected to 10% SDS-PAGE and then transferred to
nitrocellulose membranes for immunoblot analysis. Duplicate blots
were screened with antibodies to the human red cell enzyme and
rPfALAD with antibody dilutions in the range of 1:1000 to 1:2000
followed by goat anti-rabbit (human ALAD) or goat anti-mouse
(rPfALAD) antibodies conjugated to alkaline phosphatase.
For immunoelectron microscopic studies, the parasite-infected red
blood cell pellet was washed three times with phosphate-buffered saline
and then resuspended in 1% (w/v) paraformaldehyde and 0.2% (w/v)
glutaraldehyde in phosphate buffer, pH 7.1, for 3–4 h. Immunostaining
was then carried out by the protocol supplied by PELCO International
using the LR White resin. Ultrathin sections from the embedded block
were mounted on nickel grids. All incubations with antibodies were
carried out in blocking buffers containing 2% (w/v) bovine serum albu-
min. Anti-human ALAD antibodies (rabbit) or anti-rPfALAD antibod-
ies (mouse) were used at 1:200 dilution and incubated for 2–3 h. Goat
anti-rabbit or goat anti-mouse IgG coupled to 10- or 20-nm gold parti-
cles were used as secondary antibodies at 1:50 dilution and incubated
for 1 h. The grids were then post-fixed with 1% glutaraldehyde in
phosphate-buffered saline, washed with distilled water, subjected to
silver enhancement, and then counterstained with uranyl acetate in
50% (w/v) ethanol. Sections were viewed using a JOEL CX100 trans-
mission electron microscope.
Other Procedures—RNA was isolated from the parasite using Trizol
(Invitrogen, CA). Antibodies were raised to purified native human
ALAD in rabbits and to rPfALAD in mice. The parasite lysate was
prepared by resuspending the parasite pellet in 50 mM Tris, pH 8,
followed by freeze-thawing and sonication. The sonicate was then incu-
bated with 0.5% Triton X-100 for 30 min in ice to obtain the total ALAD
activity in the soluble phase. Partially purified hALAD and rPfALAD
were used as controls. The assays were done in the presence or absence
of 25 mM EDTA. Human red blood cell lysate was fractionated on a
DEAE column to remove hemoglobin and partially purify hALAD.
RESULTS
The full-length cDNA (cDNA-1) for PfALAD was cloned into
E. coli but the expression was very poor. This could be because
of the hydrophobic signal sequence at the N terminus. There-
fore cDNA-2 (56 to 451 aa) that permitted good growth of the E.
coli hemB mutant in the complementation assay (7) was cloned
into E. coli and expressed as a protein with the histidine tag or
as a GST fusion protein (Fig. 2, A and B). Application of Plas-
moAP (21), a rule-based predictor for apicoplast targeting pep-
tides within P. falciparum, revealed that the N-terminal 70
amino acids would encompass the signal and transit peptides
necessary to target ALAD to the apicoplast. Therefore, the
removal of the N-terminal stretch (1–55 amino acids) should
not affect enzyme activity. All the purified rPfALAD prepara-
tions, with histidine tag and with or without GST, were enzy-
matically active. Because, the histidine-tagged protein yields
were higher than the GST-cleaved preparation, the former was
used in most of the experiments. The purified rPfALAD (Fig.
2C) was used to raise PfALAD-specific antibodies.
Oligomeric Nature
Because most ALADs purified so far are octamers (22, 23), an
assessment of the oligomeric state of rPfALAD was made based
on the gel filtration profile on a Superdex 200 analytical FPLC
column. The results presented in Fig. 3A indicate that the
rPfALAD elutes from the column with an Mr of 345,000 com-
pared with the value of 335,000 obtained for rmALAD. The
subunit Mr values for rPfALAD and rmALAD are 46,000 and
38,000 on the basis of mobility on SDS-PAGE (Fig. 3B). Thus,
both ALAD species are octamers.
pH Optimum and Km
Because ALADs from plant sources have an alkaline pH
optimum (23), it was of interest to assess the same with
rPfALAD. The results presented in Fig. 4 reveal that rPfALAD
indeed has a pH optimum between 8 and 9, whereas rmALAD
has a pH optimum between 7.5 and 8.5. The Km value for ALA
with rPfALAD is 0.208 mM at pH 8.5, whereas for rmALAD at
pH 7.5 the value is 0.294 mM.
FIG. 2. Expression of rPfALAD as GST fusion protein or with
histidine tag. The 1191- (cDNA-2) and 678-bp (cDNA-3) products were
cloned into pGEX4T1 or pRSET vectors and the proteins were ex-
pressed with isopropyl-1-thio--D-galactopyranoside in E. coli
BL21(DE3) as described in the text. A, purification profile of rPfALAD
as a GST fusion protein. Lanes: 1, E. coli lysate supernatant; 2, flow
through from a glutathione-agarose column; 3, eluate from the column
with reduced glutathione; 4, preparation after thrombin cleavage; 5,
rPfALAD after gel filtration; 6, molecular weight markers. B, purifica-
tion profile of rPfALAD with the histidine tag. Lanes: 1, E. coli cell
lysate; 2, soluble supernatant; 3, 0–30% (NH4)2SO4 fraction; 4, eluate
from the nickel-agarose column with imidazole; 5, molecular weight
markers. C, purification profile of rPfALAD with the histidine tag.
Lanes: 1, E. coli lysate; 2, 8 M urea soluble fraction; 3, flow through from
the nickel-agarose column; 4, eluate from the nickel-agarose column
with imidazole; 5, molecular weight markers.
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Effect of Metal Ions
A considerable amount of literature exists on the metal co-
factor requirement of ALAD from different sources (22–27).
The enzyme species are classified into five different types based
on whether they require Zn2 (mammalian and yeast), Mg2
(plant, algae, and bacteria), or both (some bacteria). All the
reported enzymes are inhibited by EDTA (26) or o-phenanthro-
line (24) and the inhibition can be overcome by the addition of
Mg2 or Zn2, depending on the enzyme species. Interesting
results are obtained with rPfALAD in this regard. First of all,
rPfALAD purified as described under “Experimental Proce-
dures” and dialyzed extensively against 100 mM Tris buffer, pH
8.5, in the presence of 20% glycerol is active without addition of
any metal ion. However, addition of Mg2 stimulates enzyme
activity by 20–30% at pH 8.5. As expected, the activity of
rmALAD is not stimulated by Mg2 (Fig. 5A). The unique
features of rPfALAD are manifest in experiments studying the
effects of EDTA and o-phenanthroline. EDTA does not inhibit
rPfALAD enzyme activity even at 25 mM concentration and
overnight treatment. Treatment of the enzyme with Chelex 100
resin does not lead to loss of enzyme activity (data not pre-
sented). RmALAD is inhibited to an extent of 90% at 5 mM
EDTA concentration (Fig. 5B).
Whereas EDTA does not inhibit the basal activity of
rPfALAD, it inhibits the stimulation brought about by added
Mg2. o-Phenanthroline inhibits rmALAD activity by more
than 90% at 0.5 mM concentration and this inhibition is sub-
stantially reversed in the presence of 20–40 M Zn2. rPfALAD
activity is inhibited to 70% by o-phenanthroline at 5–10 mM
concentration and this inhibition is not reversed in the pres-
ence of 10–250 M Zn2, either at pH 7.5 or 8.5. Interestingly,
Mg2 stimulation of rPfALAD is seen with the untreated or
o-phenanthroline-treated enzyme. It is concluded that the in-
hibitory effects of o-phenanthroline on PfALAD are not related
to removal of any metal ion such as zinc. In fact, Zn2 as such
is very inhibitory to rPfALAD activity. At pH 8.5, the enzyme
activity is inhibited by 50% at 75 M Zn2, and at pH 7.5 the
metal is even more inhibitory, 50% inhibition being brought
about by less than 20 M Zn2. The 50% inhibitory value for
rmALAD at pH 7.5 is around 120 M Zn2 (data not presented).
Effect of Monovalent Cation
rPfALAD activity is also stimulated by K and this activa-
tion is pH-dependent. Between pH 6.5 and 7.0, K is as stim-
ulatory as Mg2 and the stimulation is almost 2-fold. However,
while the stimulatory effect of Mg2 (around 20–30%) is seen
FIG. 3. Elution profile of rmALAD and rPfALAD on Superdex-200 column. The two preparations were mixed and loaded onto a
Superdex-200 HR 10/30 (bed volume  24 ml) column, calibrated separately with ferritin (F), catalase (C), rmALAD (A), and ovalbumin (O).
200-l fractions were collected and the fractions were subjected to 10% SDS-PAGE. A, elution profile of rmALAD and rPfALAD in relation to the
molecular weight markers. B, SDS-PAGE analysis of the column fractions. Lanes: M, rmALAD marker. P, rPf ALAD maker. 28–38, column
fractions.
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at all pH values tested (6.5–10) the effect of K wanes at pH
values above 7 and is actually slightly inhibitory at pH 8.5 (Fig.
6). It thus appears that K and Mg2 act at different sites on
the enzyme. Atomic absorption spectrometric analysis of puri-
fied, enzymatically active rPfALAD that was dialyzed exten-
sively against 100 mM Tris buffer, pH 8.5, containing 20%
glycerol reveals that the enzyme contains 2 atoms of Mg2 per
octamer of the enzyme.
Modeling of PfALAD Structure
ALAD asymmetrically condenses two molecules of ALA to
produce PBG. The two ALA substrate molecules are distin-
guished as A- and P-site ALA because of the acetic acid and
propionic acid side chains that they contribute to the product.
The corresponding binding sites on ALAD are termed A-site
and P-site, respectively. The sequence of PfALAD is structur-
ally compatible with the TIM barrel-fold exhibited by all the
other known structures of ALAD including the human enzyme
(16, 28, 29). It also contains the additional strands and helices
located in a long extended N-terminal arm, as seen in other
ALAD structures. The structure-based alignment of the amino
acid sequence of PfALAD with PsALAD was carried out as
described under “Experimental Procedures” (Fig. 7A). A model
of the octamer was constructed for PfALAD based on the ar-
rangement seen in the PsALAD. Despite overall similarities in
sequence, subunit, and quaternary structures between
PfALAD and PsALAD, several fine differences exist. The se-
quence alignment of PfALAD with PsALAD reveals 3 single
residue deletions and 6 short insertions spanning 1–4 residues
distributed across the PfALAD primary structure. It is inter-
esting to observe that 2 of the deletions and 3 of the insertions
occur at the dimer-dimer interface such that the corresponding
residues of the A subunit can interact with those of the E
subunit. The insertion corresponding to residues 362–365 in
PfALAD is an extended loop that projects toward the tet-
rameric axis stabilized by a salt-bridge formed by Lys363 and
Asp365 present within the loop of each subunit. Because the
octamer can be viewed as two tetramers stacking against each
other, the extended loops of one tetramer stack against those of
the other. Another insertion corresponding to residues 390–
392 is at the interface of two subunits forming a dimer.
Substrate Binding Sites—The residues in both the A-site as
well as in the P-site are essentially identical in both enzymes,
suggesting a mode of binding for the substrates similar to that
in PsALAD, and indeed in all the other ALAD structures
known so far. A series of events leading to the formation of a
fully assembled active site (monomer A in dimer AB) has been
proposed for PsALAD (17). These are (a) entry of monovalent
cation to the catalytic center that is then stabilized by Asp127,
Asp131, and Ser175, a water molecule, and the amino group of
P-site ALA; (b) formation of Schiff base with the A-site ALA by
Lys205; (c) occupation of the C-site by Mg2 disrupts the inter-
action between Asp139 and Arg181. This allows Asp139 to flip
into the active site to further stabilize the A-site ALA; and (d)
formation of hydrogen bond between Asp139 and Lys229, leading
to the closure of the active site flap and formation of fully
assembled, catalysis-ready active site.
However, the substrate binding site of PfALAD appears to be
more integral because of several additional stabilizing factors
especially in the environment of Lys316 (229 in PsALAD) whose
proper orientation and interaction with the substrate are a
FIG. 4. pH profiles for rmALAD and rPfALAD enzyme activi-
ties. PIPES, Tris, and Trizma buffers were used to cover the pH range
as indicated in the text. A, rPfALAD. B, rmALAD. The enzyme activity
is expressed as mol of PBG/mg of protein/h.
FIG. 5. Effect of Mg2 and EDTA on rmALAD and rPfALAD
enzyme activities. While rmALAD was assayed at pH 7.5, rPfALAD
was assayed at pH 7.5 (data not presented) and 8.5. A, effect of Mg2 on
the two enzyme activities. B, effect of EDTA on the two enzyme activ-
ities. Open bar, rmALAD; stippled bar, rPfALAD. The activity of un-
treated enzyme (mol of PBG formed per mg of protein/h) is taken as
100%.
FIG. 6. Effect of K and Mg2 on rPfALAD enzyme activity as a
function of pH. Effect of K on enzyme activity in the presence of
added Mg2 as a function of pH. f, no metal addition; , 100 mM KCl;
Œ, 10 mM MgCl2; ‚, 100 mM KCl  10 mM MgCl2. The enzyme activity
is expressed as mol of PBG/mg of protein/h.
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FIG. 7. Modeling studies on
PfALAD. A, sequence based alignment of
PfALAD and PsALAD. Identical residues
are highlighted in black, whereas similar
residues are highlighted in gray. B, a view
of the active sites of PfALAD (green/ball
and stick) and PsALAD (red/stick). The
C atoms of the corresponding subunits
have been superposed in the two struc-
tures (root mean square deviation 1.6).
The A-site 5-fluorolevulinic acid is shown
in cyan, the P-site 5-fluorolevulinic acid is
shown in blue, and the Na ion is shown
in pink (CPK models). Lys316 and Asp216
of PfALAD are shown in yellow and their
significance is discussed in the text. C, a
view of the Mg2-binding C-site in mono-
mer A of PfALAD and PsALAD. The col-
oring and representation are the same as
that in Fig. 9B. Mg2 (CPK model) docked
into the C-site is also shown. Gln320 of
PfALAD (Q233 in PsALAD) and A-site
5-fluorolevulinic acid are shown for refer-
ence. Asp224 and Arg267 of PfALAD differ
in conformation from their corresponding
residues Asp139 and Arg181 in PsALAD
that form a salt bridge in monomer B
(open form).
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prerequisite for catalysis. These changes in PfALAD are (a)
Asp216 (131 in PsALAD) is oriented appropriately to form a salt
bridge with Lys316 replacing the Asp139-Lys229 interaction in
PsALAD. This can happen because the conformation of Asp216
is altered slightly because of the influence of an insertion at
position 205 and a change in the amino acid sequence from
position 218 to 221 in PfALAD; (b) the two adjacent residues,
Asn315 and Gln317, form bidentate hydrogen bonds in PfALAD
that are absent in PsALAD; and (c) His223, which is in the
vicinity of Lys316, keeps the Lys316 fixed and oriented (to avoid
charge repulsion) toward the substrate. PsALAD lacks this
histidine and has Gln138 in its place. Therefore, in PfALAD the
positioning of the stretch from Lys316 to Gln320 seems to be
prefixed because of the network of interactions highlighted
(Fig. 7B).
C-site Magnesium and Its Communication with the Active
Site—Glu245 in P. aeruginosa or its equivalent in plants is
responsible for coordinating Mg2 at the C-site. In PfALAD,
Glu245 is replaced by Asn331 and this change has been attrib-
uted earlier to a possible absence of C-site Mg2 binding in
PfALAD (7). However, an enhancement of catalysis in the
presence of added Mg2 has been observed in the present
study. Despite differences in amino acid residues at the C-site,
energy minimization of the PfALAD model with magnesium
docked into the site suggests that such a binding is energeti-
cally and geometrically feasible. In the PfALAD model, Asp265
(179 in PsALAD) is capable of coordinating Mg2 through its
carboxylate side chain and Asn331 is still positioned suitably for
water-mediated coordination of the Mg2 ion. In addition,
His335 in PfALAD replacing an aspartic acid in PsALAD is also
oriented appropriately for holding a Mg2 ion. Although, metal
ions have an overwhelming preference for carboxylates as their
ligands in protein structures (30, 31), nitrogen donors such as
in histidine imidazoles are also known to coordinate Mg2 (32,
33). The other residues in the vicinity capable of coordinating
Mg2 through water molecules are Arg267 and His321 (Fig. 7C).
Because the parasite is importing the hALAD, it is of interest
to compare the geometry of the PfALAD substrate binding site
with that of hALAD. Significant differences were observed
because hALAD requires Zn2 for catalytic activity. The
hALAD substrate binding site is stabilized by the presence of
Zn2, which is coordinated by 3 cysteines. Asp216 and Asp224,
which help position Lys316 appropriately for catalysis in the
PfALAD active site, are replaced by Cys124 and Cys132 in
hALAD. The amino acid corresponding to PfALAD Lys316 is
Arg221 in hALAD. In view of these differences, meaningful
comparisons between active sites of PfALAD and hALAD can-
not be made. The C-site metal binding pocket is absent in
hALAD.
Sensitivity to Succinylacetone
This inhibitor is specific for ALAD, although different ALAD
species manifest differential sensitivity (24, 34). The results
presented in Fig. 8 reveal that rPfALAD and rmALAD are
inhibited by succinylacetone, the latter being more sensitive
than the former. Both enzymes are inhibited strikingly in the
nanomolar range, 50% inhibition being brought about by 125
and 250 nM succinylacetone for rmALAD and rPfALAD, respec-
tively. The host hALAD has also been partially purified and its
succinyl acetone sensitivity is very similar to that of rmALAD.
Localization of ALAD in the Parasite
Studies were carried out to examine the localization of
PfALAD in relation to that of the host enzyme in the parasite.
Antibodies against the truncated protein rPfALAD react spe-
cifically with rPfALAD but not with the ALAD from human red
blood cells in Western blot analysis. Antibodies to the human
red blood cell ALAD are specific to the human enzyme (Fig. 9A).
The results presented in Fig. 9B reveal that both the host
ALAD and PfALAD are detected in the parasite lysate. Al-
though the concentration of the host ALAD in the parasite is
significantly higher than that of PfALAD, exact quantification
is not possible, because the blot has to be developed much
longer to obtain the weaker signal for PfALAD. These results
are also corroborated by the immunoelectron microscopic anal-
ysis of the infected red cell. The data presented in Fig. 10, A
and B, reveal that host ALAD is widely distributed in the
parasite cytoplasm and food vacuole. PfALAD signal is sparse,
although its presence in the apicoplast can be clearly seen Fig.
10, C and D. The distinctive four-membrane architecture that
characterizes the apicoplast is reported to be fragile (35). This
is the first report on the actual detection of an enzyme of the
heme-biosynthetic pathway in the apicoplast.
PfALAD and Host Enzyme Activity in the Parasite
It was of interest to assess the contribution of PfALAD to the
total enzyme activity in the parasite, in view of the earlier
reports from this laboratory on the import of the host enzyme
into the parasite (2, 3). Having observed differential sensitivity
of rPfALAD and rmALAD (as well as the native human red cell
ALAD) to EDTA, the enzyme activities were assayed in the
parasite lysate in the presence or absence of 25 mM EDTA. The
results presented in Table I reveal that with total parasite
extract the residual activity in the presence of EDTA is 13.8%,
whereas the corresponding value for the host enzyme activity is
2.8%. Therefore, the contribution of PfALAD to the total ALAD
activity in the parasite is around 11%.
DISCUSSION
The results obtained in the present study reveal that rP-
fALAD manifests properties expected of a plant-like enzyme
species (alkaline pH optima and apicoplast localization), while
at the same time manifesting certain unique properties such as
Mg2-independent and EDTA-resistant catalytic activity. In-
terestingly, the enzyme from P. aeruginosa has also been
shown not to require any divalent metal ion for activity. The
bacterial enzyme has been shown to contain 4 atoms of Mg2,
required for stabilizing the octameric structure but not essen-
tial for octamer formation or catalytic activity. This is the
lowest number of bound, divalent metal ions yet reported for all
species of ALAD except for rPfALAD, which is investigated in
the present study. Hence, the enzyme from P. aeruginosa has
been described as a novel type V ALAD (26, 36). rPfALAD
resembles the enzyme from P. aeruginosa in most of its prop-
erties, except in terms of sensitivity to EDTA and dialysis. The
dialyzed enzyme is active in the absence of added metal ions
FIG. 8. Inhibition of rPfALAD and rmALAD enzyme activities
by succinylacetone (SA). f, rPfALAD; Œ, rmALAD. The enzymes
were preincubated with succinylacetone for 20 min before the addition
of 5 mM ALA. The activity of the untreated enzyme (mol of PBG/mg of
protein/h) is taken as 100%.
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but can be stimulated by the addition of Mg2 to an extent of
20–30%. The dialyzed enzyme contains 2 atoms of bound Mg2
per octamer, the significance of which is not clear at present.
The Mg2 dependence of plant and algal ALADs in chloroplasts
has been explained because of the presence of a high concen-
tration of Mg2 (10 mM) that would help to overcome the
thermodynamic difficulty of inserting Mg2 into protoporphy-
rin IX for chlorophyll biosynthesis. This perhaps acted as the
evolutionary pressure against a chlorophyll biosynthetic en-
zyme such as ALAD, to switch over to Mg2 from Zn2 as the
metal requirement (37). Because, apicoplasts are held to be
derived from algal plastids by secondary endosymbiosis (38),
PfALAD perhaps shows Mg2 dependence for activation. How-
ever, the concentration of Mg2 in the apicoplast is not known.
The bacterial enzyme is completely inhibited by EDTA or
just by dialysis and the apoenzyme can be reconstituted by
Mg2 (26, 36). The crystal structure of ALAD from P. aerugi-
nosa reveals that Mg2 is bound 14 Å away from the Schiff
base-forming nitrogen atom of the active site lysine (16). Based
on the crystal structure of the enzyme in complex with the
inhibitor 5-fluorolevulinic acid at high resolution, the active
site has been shown to contain a monovalent cation (Na) that
may assist in enzyme activity (17). rPfALAD is similar to
PsALAD in this regard and added K stimulates the enzyme
activity in the pH range between 6.5 and 7.5. However, as
stated earlier, rPfALAD unlike PsALAD does not lose enzyme
activity on dialysis and is active in the absence of added Mg2
or K.
Homology modeling studies were done to get insight into the
unique properties of PfALAD discussed above. These studies
have shown that the alterations in interactions arising out of
the deletion and insertions in PfALAD, mentioned earlier, ne-
cessitate a minor reorientation of each subunit with respect to
the others, as compared with that in PsALAD. In addition,
there are a number of additional interactions between two
dimers (e.g. A and E subunits of AB and EF dimers) in the
PfALAD structure resulting in a stable octamer. The prefixed
FIG. 9. Localization of PfALAD in P. falciparum by Western
blot analysis. Antibodies to purified human erythroid ALAD (-
hALAD) and rPfALAD (-PfALAD) were used in these experiments.
Duplicate membrane blots were used for the analysis. A, antibody
specificity. Lanes: 1, human erythroid ALAD; 2, rPfALAD. B, detection
of host (human) and PfALAD in P. falciparum. Lanes: 1, human eryth-
roid ALAD; 2, parasite lysate, 3, rPfALAD.
FIG. 10. Localization of PfALAD in P. falciparum by immuno-
electron microscopy. A and B, localization of host ALAD in the
parasite and red blood cell. C and D, localization of PfALAD in the
apicoplast with multimembrane structure. The abundant presence of
host ALAD in the cytoplasm and food vacuole and the sparse occurrence
of PfALAD in the apicoplast (shown by the arrow) of P. falciparum is
indicated by the distribution of gold particles. Scale bar  0.5 m. Pc,
parasite cytoplasm. Rc, red cell cytoplasm. Fv, food vacuole. Ap,
apicoplast.
TABLE I
ALAD enzyme activity in P. falciparum extracts
Enzyme assay was carried out in the presence of 25 mM EDTA to
distinguish between host ALAD (sensitive) and PfALAD (insensitive).
Data given are representative of three independent experiments.
Fraction
ALAD activity
 EDTA  EDTA
mol PBG/mg protein/hr % residual activity
Total activitya in
parasite extract
0.011 13.8
Human red blood cell
ALAD (DEAE
fraction)
0.196 2.8
rPfALADb 1.89 100
a Total activity represents activity obtained from the soluble and
membrane-bound enzyme extracted as given under “Experimental Pro-
cedures.”
b rPfALAD was assayed in the absence of metal ions.
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nature of important active site amino acids (e.g. positioning of
the stretch from Lys316 to Gln320) might help to explain the
observation that metal ions (either divalent or monovalent),
which are normally required by other ALAD species to stabilize
the hydrophilic network in the active site, are not required by
PfALAD. Analysis of the PsALAD structure suggests that the
conformation of the N-terminal arm of the B-subunit is depend-
ent on the salt bridge made by Arg19 on this subunit with the
A subunit Glu245. This interaction is stabilized by magnesium
binding to the C-site, which is at the interface of A and B
subunits. In PfALAD, this interaction is absent but is compen-
sated by other salt bridges between A/B and E subunits (B:
Arg102, Arg99, Glu95 with E: Arg281, Asp282, and A: Lys232 with
E: Asp256) as well as by hydrophobic contacts between the B
and E subunits (B: Leu109, Ile103 with E: Leu284, Ile208). The
Arg181-Asp139 interaction proposed to form the communication
between the C-site and active site in PsALAD may not exist in
PfALAD although it cannot be totally ruled out. Instead,
His321, which is in the water-mediated coordination sphere of
Mg2 in PfALAD, is adjacent to Gln320 that directly interacts
with the substrate in the A-site and hence can form a probable
route of communication to the active site. Thus Mg2, although
not required for catalytic activity or stabilization of the oc-
tameric structure in PfALAD, can bind to the C-site and stim-
ulate the enzyme activity. X-ray crystal structural analysis of
PfALAD would be of considerable interest.
Expression profiling using DNA microarray (39) reveals that
PfALAD mRNA expression in the intraerythrocytic parasite is
very low. The present studies reveal that the enzyme protein
can be detected in low levels in the parasite by Western blot
analysis, immunolocalization, and enzyme activity. Thus, the
Pfalad gene is transcribed and translated. Sato and Wilson (7)
have suggested that PfALAD may be responsible for parasite
heme synthesis rather than the imported host enzyme. As a
basis for this suggestion, these authors have drawn on the
differential sensitivity between the pea versus yeast enzyme to
succinylacetone (Ki  0.3 M versus 0.8 mM) (24), implying that
the parasite enzyme is likely to resemble the pea enzyme.
However, the present studies reveal that both rPfALAD,
rmALAD and hALAD, are sensitive to succinylacetone in the
nanomolar range, the host enzyme being more sensitive than
the parasite enzyme to the inhibitor. However, the concentra-
tion of succinylacetone required to inhibit heme synthesis and
growth in P. falciparum in culture exceeds 2 mM (1, 4) and it is
obviously because of the abundance of the host ALAD in the red
cell and the parasite. Thus, the argument for the involvement
of PfALAD rather than that of the imported host enzyme in
parasite heme synthesis, based on the presumed higher sensi-
tivity of the parasite gene-coded enzyme than that of the host to
succinylacetone is not tenable. Furthermore, earlier studies
from this laboratory have shown that when P. falciparum is
cultured in erythrocytes where the host ALAD is irreversibly
inactivated by succinylacetone, the parasite ALAD levels fall
dramatically leading to inhibition of heme synthesis and death
of the parasite (2). Subsequent studies have shown that when
a truncated polypeptide of host ALAD (ALAD-NC) is added to
a culture of P. falciparum, it is taken up by the parasite and it
blocks the translocation of the host enzyme to the parasite
cytosol, leading to inhibition of parasite heme synthesis and
death of the parasite (3).
The real basis for the suggestion of Sato and Wilson (7) is the
fact that P. falciparum has a functional alad gene. The present
studies reveal that although the parasite has a functional alad
gene, its contribution to the ALAD enzyme levels of the para-
site is quantitatively small. This is borne out by a comparison
between the imported host enzyme and the parasite genome-
coded enzyme on the basis of Western blot analysis, signal
abundance in immunoelectron microscopy, and assay of en-
zyme activity. It is clear that PfALAD contributes to around
10% of the total ALAD activity of the parasite. It appears
possible that PfALAD may only take care of heme synthesis in
the apicoplast and an additional site of heme synthesis involv-
ing the parasite mitochondrion and cytosol containing the im-
ported host enzyme(s) is necessary for the synthesis of parasite
hemoproteins. This mechanism is perhaps necessary, because
there is only a single apicoplast in the parasite, unlike in plants
where chloroplasts are present abundantly. The origin of ALA
for apicoplast heme synthesis is still an open question.
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